Asia Pacific Cancer Registry Software Market By Type (Integrated and Standalone) By Deployment Type (On-premise and Cloud-based) By Component (Commercial and Public) By End User (Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers) By Country, Industry Analysis and Forecast, 2019 - 2025
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Cancer Registry Software Market
The Asia Pacific Cancer Registry Software Market would witness market growth of 11.62% CAGR during the forecast period (2019-2025). Cancer registration is central to the epidemiology of cancer and the planning and implementation of cancer policy and research. The morbidity and mortality liability of cancer is among the highest in the world in India. India has a network of cancer registries across the world. Cancer registration in India has advanced, including a number of new hospitals and population-based cancer registries. Several new initiatives, including the cancer atlas and online software services, have started to streamline the process. Nevertheless, representativeness, urban-centric data, timeliness, and accuracy of cancer data are some of the problems that still trouble the cancer registration process in India.
Most of these cancer registrars are employed in hospitals. Other work settings and centers for registrars usually involve standard-setting organizations, government agencies, central or state cancer registries, pharmaceutical companies, staffing firms, software vendors, and insurance agencies. Moreover, various self-employed cancer registrars also exist in the industry. The National Cancer Registrars Association (NCRA), a non-profit association, includes registry professionals and Certified Tumor Registrars (CTR).
Physicians require cancer data to learn further about the causes of cancer and to detect cancer earlier, which increases the chances of finding a cure. Cancer specialists make treatment choices on the basis of accurate cancer data from sources like pathologists and cytologist reports. Even after diagnosis, cancer specialists still need cancer data for long enough follow-up with the patient to decide if the treatment has succeeded and if not, to evaluate why not. Since the cancer registries deliver this type of data, they are useful research tools for individuals who are interested in etiology, diagnosis, and cancer treatment.
Based on Type, the market is segmented into Integrated and Standalone. Based on Deployment Type, the market is segmented into On-premise and Cloud-based. Based on Component, the market is segmented into Commercial and Public. Based on End User, the market is segmented into Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.
Scope of the Cancer Registry Software Market Analysis
By Deployment Type
By End User
- Government & Third party
- Research Centers
- Hospital & Medical Centers
- Private Payers
- Pharma Biotech & Medical Device Suppliers
- South Korea
- Rest of Asia Pacific
- IBM Corporation
- McKesson Corporation
- Conduent, Incorporated
- Elekta AB
- Ordinal Data, Inc.
- Onco, Inc.
- C/Net Solutions
- Rocky Mountain Cancer Data System
- Electronic Registry System, Inc.
- Himagine Solutions, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free